| abstract |
(57) [Summary]nThe present invention relates to novel 5-hydroxyalkyl-substituted phenyls, which react the corresponding benzaldehyde with a Grignard compound and then reduce the remaining functional groups, or convert the corresponding benzoate according to the usual methods. Produced by either reduction to a hydroxy compound. 5-Hydroxyalkyl-substituted phenyls are particularly suitable as active ingredients in medicaments for the treatment of dyslipidemia. |